title: Cardiomyopathy induced by performance enhancing drugs in a competitive bodybuilder.
authors.affiliation: pm124p@clinmed.gla.ac.uk
authors.forename: P B
authors.initials: PB
authors.lastname: Mark
authors.forename: S
authors.initials: S
authors.lastname: Watkins
authors.forename: H J
authors.initials: HJ
authors.lastname: Dargie
mesh_terms: D000328:Adult; D045930:Anabolic Agents / Q000009:adverse effects; D004300:Doping in Sports; D004809:Ephedrine / Q000009:adverse effects; D013006:Growth Hormone / Q000009:adverse effects; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000139:chemically induced*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D013974:Thyroxine / Q000009:adverse effects; D018487:Ventricular Dysfunction, Left / Q000139:chemically induced*
chemical_list: D045930:Anabolic Agents; D013006:Growth Hormone; D004809:Ephedrine; D013974:Thyroxine